Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does EDOXABAN TOSILATE Cause Cerebral infarction? 44 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 44 reports of Cerebral infarction have been filed in association with EDOXABAN TOSILATE. This represents 11.8% of all adverse event reports for EDOXABAN TOSILATE.

44
Reports of Cerebral infarction with EDOXABAN TOSILATE
11.8%
of all EDOXABAN TOSILATE reports
9
Deaths
37
Hospitalizations

How Dangerous Is Cerebral infarction From EDOXABAN TOSILATE?

Of the 44 reports, 9 (20.5%) resulted in death, 37 (84.1%) required hospitalization, and 4 (9.1%) were considered life-threatening.

Is Cerebral infarction Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for EDOXABAN TOSILATE. However, 44 reports have been filed with the FAERS database.

What Other Side Effects Does EDOXABAN TOSILATE Cause?

Anaemia (15) Embolic stroke (14) Off label use (14) Cerebrovascular accident (12) Epistaxis (11) Pulmonary embolism (11) Gastrointestinal haemorrhage (10) Cerebral haemorrhage (9) Death (9) Haemorrhage (9)

What Other Drugs Cause Cerebral infarction?

RIVAROXABAN (1,367) APIXABAN (937) DABIGATRAN ETEXILATE (713) ASPIRIN (535) EDOXABAN (419) CLOPIDOGREL BISULFATE (315) PEMBROLIZUMAB (295) BEVACIZUMAB (269) METHOTREXATE (265) NIVOLUMAB (262)

Which EDOXABAN TOSILATE Alternatives Have Lower Cerebral infarction Risk?

EDOXABAN TOSILATE vs EFALIZUMAB EDOXABAN TOSILATE vs EFANESOCTOCOG ALFA EDOXABAN TOSILATE vs EFAVIRENZ EDOXABAN TOSILATE vs EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL EDOXABAN TOSILATE vs EFAVIRENZ\LAMIVUDINE\TENOFOVIR DISOPROXIL

Related Pages

EDOXABAN TOSILATE Full Profile All Cerebral infarction Reports All Drugs Causing Cerebral infarction EDOXABAN TOSILATE Demographics